Due to the nature of its products, pharmaceutical and
biotech firms face very specific challenges: long
development timelines, high costs, limited funding and
high risk. These factors contribute to a mere 10% of
projects being successfully completed. This book
addresses the key challenges facing project managers of
pharmaceutical and biotech ......